The incidence of obesity is increasing in Asia, with implications on gastrointestinal (GI) and liver diseases. The Gut and Obesity in Asia Workgroup comprises regional experts with the aim of studying relationship between obesity and the GI and liver diseases in Asia. Through literature review and the modified Delphi process, consensus statements examining the impact of obesity on esophageal, gastric, pancreatic, colorectal, and liver diseases, exploring relationship between gut microbiome and obesity, and assessing obesity therapies have been produced by the Gut and Obesity in Asia Workgroup. Sixteen experts participated with 9/15 statements having strong consensus (>80

作者：Jianyi Calvin, Koh；Wai Mun, Loo；Khean Lee, Goh；Kentaro, Sugano；Wah Kheong, Chan；Wai Yan Philip, Chiu；Myung-Gyu, Choi；Sutep, Gonlachanvit；Wei-Jei, Lee；Wei Jie Jonathan, Lee；Yeong Yeh, Lee；Laurentius A, Lesmana；You-Ming, Li；Chun Jen, Liu；Bunzo, Matsuura；Atsushi, Nakajima；Enders Kwok Wai, Ng；Jose D, Sollano；Simon Kin Hung, Wong；Vincent W S, Wong；Yunsheng, Yang；Khek Yu, Ho；Yock Young, Dan

来源：Journal of gastroenterology and hepatology 2016 年 31卷 8期